Home » Topics » Regulatory » EMA

EMA
RSS

Rare Disease Day 2010 focuses attention on orphan drug development

Feb. 26, 2010

CHMP adopts positive opinion on marketing of GSK's pandemic influenza vaccine Arepanrix

Jan. 28, 2010

CHMP recommends suspension of marketing authorization for sibutramine

Jan. 26, 2010

EMEA recommends additional measures to manage risk for PML with Tysabri therapy

Jan. 26, 2010

Janssen-Cilag notifies EMEA of withdrawal of Comfyde MAA for partial-onset seizures

Jan. 26, 2010

EMEA recommends withdrawal of benfluorex from the market in E.U.

Dec. 28, 2009

Bayer Schering withdraws European MAA for Recothrom (thrombin alfa)

Dec. 16, 2009

GSK withdraws centralized MAA for Zunrisa in postoperative nausea and vomiting

Oct. 16, 2009

CHMP issues positive opinion for Baxter's Celvapan H1N1 pandemic influenza vaccine

Oct. 6, 2009

E.C. approves Novartis' Focetria vaccine for use in the H1N1 influenza pandemic

Oct. 1, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
Other news to note for July 20, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Cellution, Dimerix, Elutia, IPG, Jasper, Kira, Lumibird, Medtronic,...